Volume 27, Number 1—January 2021
Dispatch
Economic Burden of Legionnaires’ Disease, United States, 2014
Madeleine Baker-Goering
, Kakoli Roy, Chris Edens, and Sarah Collier
, Kakoli Roy, Chris Edens, and Sarah Collier
Table 2
Economic burden of Legionnaires’ disease, United States, 2014
| Type of cost | Estimate (range) |
|---|---|
| Medical costs (1) for estimate and range | $402 million ($80–$1,690 million) |
| Productivity losses from workdays lost* | $21,634,454 ($11–$31 million) |
| Productivity losses from premature deaths | $411,658,786 ($271–$542 million) |
| Total economic burden | $835,035,255 ($362–$2,263 million) |
*Productivity losses from workdays lost were calculated among nonfatal cases requiring hospitalization (10,800 patients – 995 deaths = 9,805 nonfatal cases requiring hospitalization), of which 60% are assumed to be among working-age persons (5,883). Each hospitalized patient is assumed to lose 10 workdays because of hospitalization (5883 × 10 = 58,830 workdays lost); each workday is valued at $363.36.
Page created: October 09, 2020
Page updated: December 21, 2020
Page reviewed: December 21, 2020
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.